SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615774-17-001477
Filing Date
2017-04-04
Accepted
2017-04-04 11:32:27
Documents
3
Period of Report
2017-04-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K s105791_8k.htm 8-K 12781
2 EXHIBIT 99.01 s105791_ex99-1.htm EX-99.01 10991
3 GRAPHIC pg1img1_ex99-1.jpg GRAPHIC 11727
  Complete submission text file 0001615774-17-001477.txt   41256
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 17736778
SIC: 2834 Pharmaceutical Preparations